Translating gene therapy to the clinic : techniques and approaches / (Record no. 247003)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 05691cam a2200613Ii 4500 |
001 - CONTROL NUMBER | |
control field | ocn895772596 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20190328114809.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu|||unuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 141118s2015 ne a ob 001 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | N$T |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | N$T |
Modifying agency | EBLCP |
-- | N$T |
-- | ZCU |
-- | OPELS |
-- | OCLCF |
-- | MYG |
-- | OCLCQ |
-- | UKMGB |
-- | YDXCP |
-- | YDX |
-- | MERER |
-- | OCLCO |
-- | OCLCQ |
-- | U3W |
-- | D6H |
-- | CHVBK |
-- | AU@ |
-- | WYU |
-- | CUY |
-- | LOA |
-- | OCLCQ |
-- | USU |
-- | MERUC |
-- | OCLCO |
-- | ICG |
-- | OCLCO |
-- | K6U |
-- | COCUF |
-- | VT2 |
-- | DKC |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
Record control number | 016965687 |
Source | Uk |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
Record control number | 016963762 |
Source | Uk |
019 ## - | |
-- | 897881152 |
-- | 898418256 |
-- | 907378542 |
-- | 992488055 |
-- | 1066623932 |
-- | 1088968408 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780128005644 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0128005645 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9780128005637 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 0128005637 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)895772596 |
Canceled/invalid control number | (OCoLC)897881152 |
-- | (OCoLC)898418256 |
-- | (OCoLC)907378542 |
-- | (OCoLC)992488055 |
-- | (OCoLC)1066623932 |
-- | (OCoLC)1088968408 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RB155.8 |
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | 2015 A-003 |
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | QU 560 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 071000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.8/95 |
Edition number | 23 |
245 00 - TITLE STATEMENT | |
Title | Translating gene therapy to the clinic : techniques and approaches / |
Medium | [electronic resource] |
Statement of responsibility, etc. | edited by Jeffrey Laurence, Michael Franklin. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Amsterdam : |
Name of producer, publisher, distributor, manufacturer | Academic Press, an imprint of Elsevier, |
Date of production, publication, distribution, manufacture, or copyright notice | 2015 |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | �2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource : |
Other physical details | color illustrations. |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
490 1# - SERIES STATEMENT | |
Series statement | Advances in translational research |
588 0# - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Online resource; title from PDF title page (Ebsco, viewed Dec. 18, 2014). |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Translating Gene Therapy to the Clinic, edited by Dr. Jeffrey Laurence and Michael Franklin, follows the recent, much-lauded special issue of Translational Research in emphasizing clinical milestones and critical barriers to further progress in the clinic. This comprehensive text provides a background for understanding the techniques involved in human gene therapy trials, and expands upon the disease-specific situations in which these new approaches currently have the greatest therapeutic application or potential, and those areas most in need of future research. It emphasizes methods, tools, and experimental approaches used by leaders in the field of translational gene therapy. The book promotes cross-disciplinary communication between the sub-specialties of medicine, and remains unified in theme. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Front Cover; Translating Gene Therapy to the Clinic: Techniques and Approaches; Copyright; Contents; Preface; REFERENCES; About the Editors; Contributors; Chapter 1 -- Translating Genome Engineering to Survival; 1.1 ORIGINS; 1.2 SYNCHRONICITY OF DISCOVERIES; 1.3 GENE ADDITION; 1.4 FROM GENE ADDITION TO GENE EDITING; 1.5 THERAPY FOR GENETIC DISORDERS; 1.6 ROADMAP TO THE FUTURE; CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES; Chapter 2 -- Pluripotent Stem Cells and Gene Therapy; 2.1 GENETIC APPROACHES TO PLURIPOTENCY; 2.2 TRANSCRIPTION FACTORS IMPORTANT FOR REPROGRAMMING TO PLURIPOTENCY. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 2.3 METHODS FOR GENETIC REPROGRAMMING2.4 CLINICAL TRANSLATION OF IPSCS; 2.5 CONCLUSION; REFERENCES; Chapter 3 -- Genome Engineering for Therapeutic Applications; 3.1 INTRODUCTION; 3.2 CUSTOMIZABLE DNA-TARGETING PROTEINS; 3.3 GENOME EDITING WITH ENGINEERED NUCLEASES; 3.4 SYNTHETIC TRANSCRIPTION FACTORS FOR THERAPEUTIC APPLICATIONS; 3.5 CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 4 -- Immune System Obstacles to In vivo Gene Transfer with Adeno-Associated Virus Vectors; 4.1 INTRODUCTION; 4.2 AAV VECTORS; 4.3 INNATE IMMUNITY IN AAV GENE TRANSFER; 4.4 T-CELL RESPONSES TO VECTORS. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 4.5 HUMORAL IMMUNITY4.6 CONCLUSIONS; ACKNOWLEDGMENT; REFERENCES; Chapter 5 -- Risks of Insertional Mutagenesis by DNA Transposons in Cancer Gene Therapy; 5.1 INSERTIONAL MUTAGENESIS-THE DOWNSIDE OF GENE THERAPY?; 5.2 SLEEPING BEAUTY TRANSPOSON/TRANSPOSASE SYSTEM ADAPTED FOR GENE THERAPY; 5.3 PLASTICITY OF GENOMES AND GENE EXPRESSION IN HUMANS; 5.4 TRANSPOSON-MEDIATED GENE THERAPY IN THE CLINIC; 5.5 CONCLUSIONS; ACKNOWLEDGMENT; REFERENCES; Chapter 6 -- Arthritis Gene Therapy: A Brief History and Perspective; 6.1 INTRODUCTION; 6.2 CONCEPTION AND STRATEGIES; 6.3 TECHNOLOGY DEVELOPMENT. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 6.4 UNRESOLVED ISSUES6.5 CLINICAL TRIALS; 6.6 VETERINARY APPLICATIONS; 6.7 OTHER APPLICATIONS OF INTRA-ARTICULAR GENE THERAPY; 6.8 COMMERCIALIZATION; 6.9 PERSPECTIVES; ACKNOWLEDGMENTS; REFERENCES; Chapter 7 -- Type 1 Diabetes Mellitus: Immune Modulation as a Prerequisite for Successful Gene Therapy Strategies; 7.1 INTRODUCTION; 7.2 EFFECTIVE IMMUNE THERAPY/MODULATION: A PREREQUISITE FOR SUCCESSFUL GENE THERAPY OF TYPE 1 DIABETES; 7.3 TARGETED ISLET ANTIGEN RECOGNITION AND ANTIGEN-BASED THERAPIES; 7.4 BROAD IMMUNOSUPPRESSIVE THERAPIES; 7.5 IMMUNOTHERAPIES THAT TARGET EVENTS IN T CELL RESPONSE. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Gene therapy. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Pharmacology. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Gene therapy. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst00939638 |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Genetic Therapy |
General subdivision | methods. |
Authority record control number | (DNLM)D015316Q000379 |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Translational Medical Research. |
Authority record control number | (DNLM)D057170 |
655 #0 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic book. |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
655 #7 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
Source of term | lcgft |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Laurence, Jeffrey, |
Relator term | editor. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Franklin, Michael, |
Relator term | editor. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Title | Translating gene therapy to the clinic. |
Place, publisher, and date of publication | [S.l.] : Elsevier Academic Press, 2015 |
International Standard Book Number | 0128005637 |
-- | 9780128005637 |
Record control number | (OCoLC)884300585 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Advances in translational research. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | ScienceDirect |
Uniform Resource Identifier | http://www.sciencedirect.com/science/book/9780128005637 |
No items available.